PharmAbcine to participate in J.P. Morgan Healthcare Conference and Biotech Showcase during J.P. Morgan Week 2022

/PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics,...

Related Keywords

Australia ,Daejeon ,Taejon Gwangyoksi ,South Korea ,San Francisco ,California ,United States ,Paul Kim ,Jin San Yoo ,Pharmabcine Inc ,Ir Pr Team ,Youtube ,Linkedin ,Business Development Team ,Human Research Ethics ,Chief Executive Officer ,Healthcare Conference ,Biotech Showcase ,Vascular Endothelial Growth Factor Receptor ,Human Research Ethics Committees ,Triple Negative Breast Cancer ,Age Related Macular Degeneration ,Diabetic Retinopathy ,Diabetic Macular Edema ,V Domain Ig Suppressor ,Myeloid Derived Suppressor Cells ,Chief Financial ,Pharmabcine ,